OncoCyte Corporation (OCX)
NASDAQ: OCX · Real-Time Price · USD
2.190
-0.020 (-0.91%)
Dec 20, 2024, 4:00 PM EST - Market closed
OncoCyte Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 37 | 21 | 38 | 200 | 161 | 117 | |
| Market Cap Growth | 48.24% | -45.76% | -80.98% | 24.52% | 37.45% | 108.38% | |
| Enterprise Value | 37 | 14 | 14 | 162 | 159 | 98 | |
| Last Close Price | 2.19 | 2.50 | 6.42 | 43.40 | 47.80 | 45.00 | |
| PS Ratio | 33.31 | 13.74 | 39.74 | 91.06 | 132.18 | - | |
| PB Ratio | 3.02 | 0.81 | 0.96 | 3.07 | 4.80 | 3.79 | |
| P/TBV Ratio | - | - | - | - | 17.31 | 3.79 | |
| EV/Sales Ratio | 52.89 | 9.60 | 15.07 | 73.75 | 130.37 | - | |
| Debt / Equity Ratio | 0.41 | 0.11 | 0.09 | 0.09 | 0.26 | 0.19 | |
| Asset Turnover | 0.01 | 0.02 | 0.01 | 0.02 | 0.03 | - | |
| Quick Ratio | 0.39 | 1.38 | 1.85 | 2.50 | 0.89 | 5.06 | |
| Current Ratio | 0.53 | 1.49 | 2.11 | 2.77 | 1.03 | 5.17 | |
| Return on Equity (ROE) | -165.32% | -76.26% | -35.52% | -88.37% | -93.07% | -130.91% | |
| Return on Assets (ROA) | -18.84% | -15.91% | -13.88% | -13.82% | -42.66% | -56.30% | |
| Return on Capital (ROIC) | -48.27% | -38.88% | -31.60% | -26.30% | -51.52% | -66.32% | |
| Earnings Yield | -118.28% | -134.52% | -191.48% | -32.03% | -18.62% | -19.18% | |
| FCF Yield | -55.19% | -114.30% | -131.09% | -19.08% | -16.93% | -17.64% | |
| Buyback Yield / Dilution | -52.57% | -38.10% | -24.61% | -35.80% | -27.65% | -35.52% | |
| Total Shareholder Return | -52.57% | -38.10% | -24.61% | -35.80% | -27.65% | -35.52% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.